335
Participants
Start Date
August 31, 2015
Primary Completion Date
September 20, 2016
Study Completion Date
September 20, 2016
biphasic insulin aspart 30
Injected s.c./subcutaneously once daily with the largest meal Subjects should continue their pre-trial metformin and sulfonylurea dosages all throughout the trial while other oral antidiabetic drugs will be discontinued.
insulin glargine
Injected s.c./subcutaneously once daily at the same time every day, with the possibility of treatment intensification with insulin aspart (Basal-bolus arm) Subjects should continue their pre-trial metformin and sulfonylurea dosages all throughout the trial while other oral antidiabetic drugs will be discontinued.
insulin aspart
Injected s.c./subcutaneously once daily.
Novo Nordisk Investigational Site, Umm Al Quwain City
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Sofia
Novo Nordisk Investigational Site, Sofia
Novo Nordisk Investigational Site, Sofia
Novo Nordisk Investigational Site, Broadmeadow
Novo Nordisk Investigational Site, Coffs Harbour
Novo Nordisk Investigational Site, Petrich
Novo Nordisk Investigational Site, Melbourne
Novo Nordisk Investigational Site, Fitzroy
Novo Nordisk Investigational Site, Ipswich
Novo Nordisk Investigational Site, Nyíregyhaza
Novo Nordisk Investigational Site, Ras al-Khaimah
Novo Nordisk Investigational Site, Sliven
Novo Nordisk Investigational Site, Bangkok
Novo Nordisk Investigational Site, Bangkok
Novo Nordisk Investigational Site, Bangkoknoi, Bangkok
Novo Nordisk Investigational Site, Belgrade
Novo Nordisk Investigational Site, Belgrade
Novo Nordisk Investigational Site, Niš
Novo Nordisk Investigational Site, Ajman
Novo Nordisk Investigational Site, Dubai
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Khon Kaen
Novo Nordisk Investigational Site, Malatya
Novo Nordisk Investigational Site, Rize
Novo Nordisk Investigational Site, New Delhi
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Vellore
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Madurai
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Antalya
Lead Sponsor
Novo Nordisk A/S
INDUSTRY